155 related articles for article (PubMed ID: 29262742)
21. Invasive fungal infections in hemato-oncology.
Oberoi JK; Sheoran L; Sagar T; Saxena S
Indian J Med Microbiol; 2023; 44():100353. PubMed ID: 37356843
[TBL] [Abstract][Full Text] [Related]
22. Voriconazole therapeutic drug monitoring in critically ill patients improves efficacy and safety of antifungal therapy.
Li H; Li M; Yan J; Gao L; Zhou L; Wang Y; Li Q; Wang J; Chen T; Wang T; Zheng J; Qiang W; Zhang Y; Shi Q
Basic Clin Pharmacol Toxicol; 2020 Dec; 127(6):495-504. PubMed ID: 32639669
[TBL] [Abstract][Full Text] [Related]
23. Antifungal Therapy in Pediatric Acute Lymphoblastic Leukemia: A Single-center Experience.
Yigit M; Arman Bilir Ö; Kanik Yüksek S; Kaçar D; Özbek NY; Yarali HN
J Pediatr Hematol Oncol; 2022 Apr; 44(3):e653-e657. PubMed ID: 34486550
[TBL] [Abstract][Full Text] [Related]
24. Pharmacist review of high-risk haematology outpatients to improve appropriateness of antifungal prophylaxis.
Reslan Z; Lindsay J; Kerridge I; Gellatly R
Int J Clin Pharm; 2020 Dec; 42(6):1412-1418. PubMed ID: 33009604
[TBL] [Abstract][Full Text] [Related]
25. The impact of antifungal prophylaxis in patients diagnosed with acute leukemias undergoing induction chemotherapy: a systematic review and meta-analysis.
Soldi LR; Coelho YNB; Paranhos LR; Silva MJB
Clin Exp Med; 2023 Nov; 23(7):3231-3249. PubMed ID: 37058186
[TBL] [Abstract][Full Text] [Related]
26. Using Child-Pugh Class to Optimize Voriconazole Dosage Regimens and Improve Safety in Patients with Liver Cirrhosis: Insights from a Population Pharmacokinetic Model-based Analysis.
Wang T; Yan M; Tang D; Dong Y; Zhu L; Du Q; Sun D; Xing J; Dong Y
Pharmacotherapy; 2021 Feb; 41(2):172-183. PubMed ID: 33064889
[TBL] [Abstract][Full Text] [Related]
27. First case of proven invasive pulmonary infection due to Trichoderma longibrachiatum in a neutropenic patient with acute leukemia.
Sautour M; Chrétien ML; Valot S; Lafon I; Basmaciyan L; Legouge C; Verrier T; Gonssaud B; Abou-Hanna H; Dalle F; Caillot D
J Mycol Med; 2018 Dec; 28(4):659-662. PubMed ID: 30477694
[TBL] [Abstract][Full Text] [Related]
28. Voriconazole and its clinical potential in the prophylaxis of systemic fungal infection in patients with hematologic malignancies: a perspective review.
Zabalza A; Gorosquieta A; Equiza EP; Olavarria E
Ther Adv Hematol; 2013 Jun; 4(3):217-30. PubMed ID: 23730499
[TBL] [Abstract][Full Text] [Related]
29. Effects of antifungal stewardship using therapeutic drug monitoring in voriconazole therapy on the prevention and control of hepatotoxicity and visual symptoms: A multicentre study conducted in Japan.
Hamada Y; Ueda T; Miyazaki Y; Nakajima K; Fukunaga K; Miyazaki T; Nakada-Motokawa N; Nagao M; Kawamura H; Shigemi A; Ebihara F; Kimura T; Ikegame K; Uchino M; Ikeuchi H; Takesue Y
Mycoses; 2020 Aug; 63(8):779-786. PubMed ID: 32510723
[TBL] [Abstract][Full Text] [Related]
30. A plain language summary on preventing fungal infections with isavuconazole in people with blood-related conditions.
Ping Y; Hongmei J; Bellmann C; Inês M; Macmillan T; Webb N; Aram JA; Penack O
Future Microbiol; 2023 Sep; 18():861-866. PubMed ID: 37641932
[TBL] [Abstract][Full Text] [Related]
31. Voriconazole plasma concentrations and dosing in paediatric patients below 24 months of age.
Gastine SE; Rauwolf KK; Pieper S; Hempel G; Lehrnbecher T; Tragiannidis A; Groll AH
Mycoses; 2023 Nov; 66(11):969-976. PubMed ID: 37553971
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of the prescription, consumption and costs of antifungal drugs in a pediatric hospital in Chile].
Barraza M; Barnafi N; Ortiz G; Torres JP; Coria P; Catalán P; Palma J; Morales J
Rev Chilena Infectol; 2018 Aug; 35(4):351-357. PubMed ID: 30534920
[TBL] [Abstract][Full Text] [Related]
33. [First Hungarian report of Geotrichum capitatum/Saprochaete capitata infection in an immunocompromised child].
Pásztor-Bazsó V; Kelemen Á; Varga Á; Farkas M; Puskás N; Kassa C; Hauser P
Orv Hetil; 2023 Jul; 164(26):1034-1038. PubMed ID: 37393545
[TBL] [Abstract][Full Text] [Related]
34. An Observational Study of the Efficacy and Safety of Voriconazole in a Real-Life Clinical Setting.
Blanco-Dorado S; Cea-Arestin C; González Carballo A; Latorre-Pellicer A; Maroñas Amigo O; Barbeito Castiñeiras G; Pérez Del Molino Bernal ML; Campos-Toimil M; Fernández-Ferreiro A; Lamas MJ
J Chemother; 2019 Feb; 31(1):49-57. PubMed ID: 30580667
[TBL] [Abstract][Full Text] [Related]
35. Choice and duration of antifungal prophylaxis and treatment in high-risk haematology patients.
Coussement J; Lindsay J; Teh BW; Slavin M
Curr Opin Infect Dis; 2021 Aug; 34(4):297-306. PubMed ID: 34039878
[TBL] [Abstract][Full Text] [Related]
36. Frequency of the CYP2C19*17 polymorphism in a Chilean population and its effect on voriconazole plasma concentration in immunocompromised children.
Espinoza N; Galdames J; Navea D; Farfán MJ; Salas C
Sci Rep; 2019 Jun; 9(1):8863. PubMed ID: 31222084
[TBL] [Abstract][Full Text] [Related]
37. Treatment of immunocompromised patients with suspected invasive fungal infections: economic analysis of diagnostic-driven versus empirical strategies in Algeria and Egypt.
Kaci Z; Shalaby L; Kamal S; Boudjerra N; Gao X; Xue M; Ait Belkacem S; Gab Allah Ibrahim A; Kotb R; Charbonneau C
Expert Rev Pharmacoecon Outcomes Res; 2019 Dec; 19(6):693-700. PubMed ID: 31055986
[No Abstract] [Full Text] [Related]
38. Voriconazole inhalation powder: A novel therapeutic alternative for invasive pulmonary fungal infections.
Gardiner BJ; Ivulich SP; Snell GI
Transpl Infect Dis; 2024 Jun; 26(3):e14264. PubMed ID: 38465782
[No Abstract] [Full Text] [Related]
39. Tolerability of oral itraconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A systematic review and meta-analysis.
Olum R; Baluku JB; Kazibwe A; Russell L; Bongomin F
PLoS One; 2020; 15(10):e0240374. PubMed ID: 33052954
[TBL] [Abstract][Full Text] [Related]
40. Defining standards of CARE for invasive fungal diseases in adult haematology patients: antifungal prophylaxis versus treatment.
Barnes R; Rogers T; Maertens J
J Antimicrob Chemother; 2019 Mar; 74(Suppl 2):ii21-ii26. PubMed ID: 31222310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
